Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.330
-0.050 (-3.62%)
At close: Mar 6, 2026, 4:00 PM EST
1.340
+0.010 (0.75%)
After-hours: Mar 6, 2026, 5:59 PM EST
Vivos Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vivos Therapeutics stock have an average target of 6.25, with a low estimate of 5.50 and a high estimate of 7.00. The average target predicts an increase of 369.92% from the current stock price of 1.33.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 3, 2025.
Analyst Ratings
The average analyst rating for Vivos Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.5 → $5.5 | Strong Buy | Maintains | $6.5 → $5.5 | +313.53% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +426.32% | Nov 17, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.2 → $6.5 | Strong Buy | Maintains | $6.2 → $6.5 | +388.72% | Sep 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.6 → $6.2 | Strong Buy | Maintains | $6.6 → $6.2 | +366.17% | Apr 15, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +396.24% | Nov 20, 2024 |
Financial Forecast
Revenue This Year
19.75M
from 15.03M
Increased by 31.42%
Revenue Next Year
29.59M
from 19.75M
Increased by 49.82%
EPS This Year
-2.07
from -2.22
EPS Next Year
-1.28
from -2.07
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 21.9M | 33.1M |
| Avg | 19.8M | 29.6M |
| Low | 15.0M | 22.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 46.0% | 67.4% |
| Avg | 31.4% | 49.8% |
| Low | -0.0% | 14.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -2.05 | -0.89 |
| Avg | -2.07 | -1.28 |
| Low | -2.09 | -1.68 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.